Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-04-22 @ 2:55 PM
Study NCT ID:
NCT02449551
Status:
COMPLETED
Last Update Posted:
2022-06-15
First Post:
2015-05-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of AZD6094 (Volitinib) in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment
Sponsor:
Samsung Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-14
First Submit QC Date:
None
Study First Post Date:
2015-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-13
Last Update Post Date:
2022-06-15
Last Update Post Date Type:
ACTUAL